HIF1A and neoplasm: In addition, the hypoxia transcription factor HIF-1a subdomain can be incorporated in a CAR construct to reduce on-target off-tumor toxicity, ensuring CAR T cells activation only under the hypoxic conditions characteristic of the TME (125).